DPP4 and diabetic retinopathy: Moreover, the dipeptidyl peptidase-4 (DPP-4) Inhibitor could exacerbate vascular leakage from the retina by increasing phosphorylation of Src and VE-cadherin in a mouse diabetic retinopathy model (Labat-gest and Tomasi, 2013).